• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早发型和晚发型阿尔茨海默病:它们是同一实体吗?

Early- and late-onset Alzheimer disease: Are they the same entity?

作者信息

Tellechea P, Pujol N, Esteve-Belloch P, Echeveste B, García-Eulate M R, Arbizu J, Riverol M

机构信息

Departamento de Neurología, Clínica Universidad de Navarra, Pamplona, Navarra, España.

Departamento de Radiología, Clínica Universidad de Navarra, Pamplona, Navarra, España.

出版信息

Neurologia (Engl Ed). 2018 May;33(4):244-253. doi: 10.1016/j.nrl.2015.08.002. Epub 2015 Nov 3.

DOI:10.1016/j.nrl.2015.08.002
PMID:26546285
Abstract

Early-onset Alzheimer disease (EOAD), which presents in patients younger than 65 years, has frequently been described as having different features from those of late-onset Alzheimer disease (LOAD). This review analyses the most recent studies comparing the clinical presentation and neuropsychological, neuropathological, genetic, and neuroimaging findings of both types in order to determine whether EOAD and LOAD are different entities or distinct forms of the same entity. We observed consistent differences between clinical findings in EOAD and in LOAD. Fundamentally, the onset of EOAD is more likely to be marked by atypical symptoms, and cognitive assessments point to poorer executive and visuospatial functioning and praxis with less marked memory impairment. Alzheimer-type features will be more dense and widespread in neuropathology studies, with structural and functional neuroimaging showing greater and more diffuse atrophy extending to neocortical areas (especially the precuneus). In conclusion, available evidence suggests that EOAD and LOAD are 2 different forms of a single entity. LOAD is likely to be influenced by ageing-related processes.

摘要

早发性阿尔茨海默病(EOAD)出现在65岁以下的患者中,人们经常描述它具有与晚发性阿尔茨海默病(LOAD)不同的特征。本综述分析了最近比较这两种类型的临床表现、神经心理学、神经病理学、遗传学和神经影像学研究结果的研究,以确定EOAD和LOAD是不同的实体还是同一实体的不同形式。我们观察到EOAD和LOAD的临床发现存在一致差异。从根本上说,EOAD的发病更可能以非典型症状为特征,认知评估表明执行功能、视觉空间功能和实践能力较差,记忆损害不太明显。在神经病理学研究中,阿尔茨海默病类型的特征会更密集、更广泛,结构和功能神经影像学显示萎缩更大、更弥漫,延伸至新皮质区域(尤其是楔前叶)。总之,现有证据表明EOAD和LOAD是单一实体的两种不同形式。LOAD可能受衰老相关过程的影响。

相似文献

1
Early- and late-onset Alzheimer disease: Are they the same entity?早发型和晚发型阿尔茨海默病:它们是同一实体吗?
Neurologia (Engl Ed). 2018 May;33(4):244-253. doi: 10.1016/j.nrl.2015.08.002. Epub 2015 Nov 3.
2
[Neuropsychological differences in Alzheimer's disease depending on the age of onset].[早发性与晚发性阿尔茨海默病的神经心理学差异]
Rev Esp Geriatr Gerontol. 2024 Jan-Feb;59(1):101433. doi: 10.1016/j.regg.2023.101433. Epub 2023 Dec 1.
3
Differentiated clinical presentation of early and late-onset Alzheimer's disease: is 65 years of age providing a reliable threshold?早发型和晚发型阿尔茨海默病的不同临床表现:65岁是一个可靠的阈值吗?
J Neurol. 2015 May;262(5):1238-46. doi: 10.1007/s00415-015-7698-3. Epub 2015 Mar 21.
4
Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment.早发性和晚发性阿尔茨海默病与不同的记忆障碍模式相关。
Cortex. 2016 Jan;74:217-32. doi: 10.1016/j.cortex.2015.10.014. Epub 2015 Nov 17.
5
[Features of the clinical and neuroimaging picture in patients with early-onset Alzheimer's disease].[早发型阿尔茨海默病患者的临床及神经影像学特征]
Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(4. Vyp. 2):56-63. doi: 10.17116/jnevro202412404256.
6
The topography of grey matter involvement in early and late onset Alzheimer's disease.早发性和晚发性阿尔茨海默病中灰质受累的地形图。
Brain. 2007 Mar;130(Pt 3):720-30. doi: 10.1093/brain/awl377. Epub 2007 Feb 9.
7
Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.晚发性阿尔茨海默病家族中的早发性阿尔茨海默病:家族性阿尔茨海默病的一种潜在重要亚型。
Arch Neurol. 2006 Sep;63(9):1307-11. doi: 10.1001/archneur.63.9.1307.
8
Early-onset Alzheimer's disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late-onset.早发性阿尔茨海默病表现出与晚发性不同的神经心理学特征以及更具侵袭性的认知衰退轨迹。
Ann Clin Transl Neurol. 2022 Dec;9(12):1962-1973. doi: 10.1002/acn3.51689. Epub 2022 Nov 17.
9
Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer's disease.早发型与晚发型遗忘型阿尔茨海默病神经退行性变影像学生物标志物的差异
Neurobiol Aging. 2017 Jun;54:22-30. doi: 10.1016/j.neurobiolaging.2017.02.010. Epub 2017 Feb 21.
10
Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD.早发性阿尔茨海默病:非遗忘亚型和 2 型 AD。
Arch Med Res. 2012 Nov;43(8):677-85. doi: 10.1016/j.arcmed.2012.11.009. Epub 2012 Nov 21.

引用本文的文献

1
Clinical profile of early-onset Alzheimer's disease in Peru: case series from a neurological care center.秘鲁早发性阿尔茨海默病的临床概况:来自神经护理中心的病例系列
Rev Peru Med Exp Salud Publica. 2025 Aug 25;42(2):196-202. doi: 10.17843/rpmesp.2025.422.14413.
2
Recent Advances and Future Directions in Alzheimer's Disease Genetic Research.阿尔茨海默病遗传研究的最新进展与未来方向
Int J Mol Sci. 2025 Aug 13;26(16):7819. doi: 10.3390/ijms26167819.
3
Retinal manifestations and their diagnostic significance in Alzheimer's disease.
阿尔茨海默病的视网膜表现及其诊断意义。
J Alzheimers Dis Rep. 2025 Aug 10;9:25424823251361937. doi: 10.1177/25424823251361937. eCollection 2025 Jan-Dec.
4
Divergent effects of age on imaging-based ATN biomarkers and cognition in Alzheimer's disease.年龄对阿尔茨海默病中基于影像学的急性肾损伤生物标志物及认知功能的不同影响。
Alzheimers Dement (Amst). 2025 Aug 11;17(3):e70142. doi: 10.1002/dad2.70142. eCollection 2025 Jul-Sep.
5
Facets of language performance in early-onset and late-onset Alzheimer's disease dementia.早发性和晚发性阿尔茨海默病性痴呆的语言表现方面
medRxiv. 2025 Jun 16:2025.06.13.25329521. doi: 10.1101/2025.06.13.25329521.
6
The Conceivable Role of Metabolic Syndrome in the Pathogenesis of Alzheimer's Disease: Cellular and Subcellular Alterations in Underpinning a Tale of Two.代谢综合征在阿尔茨海默病发病机制中可能扮演的角色:支撑“双故事”的细胞及亚细胞改变
Neuromolecular Med. 2025 May 16;27(1):35. doi: 10.1007/s12017-025-08832-6.
7
Lipopolysaccharides from indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentration environment in Alzheimer's disease.来自[具体来源未提及]的脂多糖间接诱导神经元中依赖糖原合酶激酶3β(GSK3β)的突触缺陷,并在阿尔茨海默病低淀粉样β蛋白浓度环境中导致认知能力下降。
J Alzheimers Dis. 2025 May;105(1):302-316. doi: 10.1177/13872877251326879. Epub 2025 Mar 20.
8
Effect of Steroids on the Progression of Alzheimer's Dementia: A Retrospective Chart Review.类固醇对阿尔茨海默病痴呆进展的影响:一项回顾性病历审查
Aging Med (Milton). 2025 Feb 18;8(1):e70004. doi: 10.1002/agm2.70004. eCollection 2025 Feb.
9
PPIA-coExp: Discovering Context-Specific Biomarkers Based on Protein-Protein Interactions, Co-Expression Networks, and Expression Data.PPIA共表达:基于蛋白质-蛋白质相互作用、共表达网络和表达数据发现特定背景下的生物标志物。
Int J Mol Sci. 2024 Nov 24;25(23):12608. doi: 10.3390/ijms252312608.
10
Biomarker and neuropsychological correlates of the N400 event-related potential in Alzheimer's disease.阿尔茨海默病中N400事件相关电位的生物标志物与神经心理学关联
Int J Psychophysiol. 2025 Jan;207:112464. doi: 10.1016/j.ijpsycho.2024.112464. Epub 2024 Nov 19.